| Quarter | Action | Shares change | Est. value change | Δ Own | Shares held | Filing date |
|---|---|---|---|---|---|---|
| Q4 2025 | Exited | −39K | −$1.1M | −100.0% | 0 | Feb 17, 2026 |
| Q3 2025 | Added | +19K | +$566K | +93.0% | 39K | Nov 13, 2025 |
| Q2 2025 | Unchanged | – | – | – | 20K | Aug 13, 2025 |
| Q1 2025 | New | +20K | +$479K | – | 20K | May 14, 2025 |
| Q1 2021 | First covered | – | – | – | 722K | May 13, 2021 |
Not currently. Jeremy Grantham fully exited CCL in Q4 2025, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
Jeremy Grantham held CCL since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
Yes. Jeremy Grantham reduced and then fully exited CCL by Q4 2025; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
None as of the latest filing: Jeremy Grantham has exited CCL. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
Jeremy Grantham's estimated average buy price for CCL is $26.87, from quarter-average prices weighted by the shares added each quarter. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.
